← All trials
NCT06077669
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2024
- Primary completion
- Dec 31, 2028
- Completion date
- Jan 31, 2029
- First posted
- Oct 11, 2023
- Last posted
- Dec 26, 2023
- Enrollment
- 80
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Johns Hopkins UniversityLead sponsor
- Johns Hopkins UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.